Insights

Innovative Diagnostic Technology Sight Diagnostics has developed advanced blood analysis tools based on proprietary imaging and AI technology, presenting opportunities to expand into hospitals, clinics, and laboratories seeking high-accuracy, rapid blood testing solutions.

Strategic Funding & Growth With a substantial funding of 99 million USD and notable investments from strategic players like Koch Industries and OurCrowd, the company is positioned for accelerated market expansion and product adoption in the biotech and medical device sectors.

Recent Product Launches The launch of the Sight OLO blood analyzer highlights a focus on user-friendly, efficient diagnostic devices, creating potential sales avenues within healthcare providers aiming to upgrade their lab capabilities with AI-powered solutions.

Market Penetration Opportunities Operating in the global biotech research industry with a focus on immune-related diagnostics, Sight Diagnostics offers opportunities to collaborate with health systems and research institutions looking for cutting-edge, biologically backed imaging diagnostics.

Global Clinical Collaborations Ongoing partnerships with prominent hospitals and research labs, such as Shaare Zedek, suggest readiness for selling advanced technological solutions to healthcare providers committed to improving treatment speed and accuracy through innovative diagnostics.

Sight Tech Stack

Sight uses 8 technology products and services including Amazon Web Services, Snowflake, Jupyter, and more. Explore Sight's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Snowflake
    Data Management Platforms
  • Jupyter
    File Sharing
  • OneDrive
    File Sharing
  • ISO/IEC 27001
    Governance, Risk And Compliance
  • Salesforce Marketing Cloud Account Engagement
    Marketing Automation
  • LinkedIn
    Online Community Software
  • Cowboy
    Web And Application Servers

Media & News

Sight's Email Address Formats

Sight uses at least 1 format(s):
Sight Email FormatsExamplePercentage
First@sightdx.comJohn@sightdx.com
52%
First.Last@sightdx.comJohn.Doe@sightdx.com
45%
First.Middle@sightdx.comJohn.Michael@sightdx.com
2%
FLast@sightdx.comJDoe@sightdx.com
1%

Frequently Asked Questions

Where is Sight's headquarters located?

Minus sign iconPlus sign icon
Sight's main headquarters is located at 23 Menahem Begin street, Tel Aviv, Israel 6618356, IL. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Sight's phone number?

Minus sign iconPlus sign icon
You can contact Sight's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sight's stock symbol?

Minus sign iconPlus sign icon
Sight is a publicly traded company; the company's stock symbol is INAQ-WT.

What is Sight's official website and social media links?

Minus sign iconPlus sign icon
Sight's official website is sightdx.com and has social profiles on LinkedIn.

What is Sight's SIC code NAICS code?

Minus sign iconPlus sign icon
Sight's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Sight have currently?

Minus sign iconPlus sign icon
As of October 2025, Sight has approximately 68 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief People Officer: I. S.Chief Financial Officer: Y. S.Chief Product Officer: A. C. D.. Explore Sight's employee directory with LeadIQ.

What industry does Sight belong to?

Minus sign iconPlus sign icon
Sight operates in the Biotechnology Research industry.

What technology does Sight use?

Minus sign iconPlus sign icon
Sight's tech stack includes Amazon Web ServicesSnowflakeJupyterOneDriveISO/IEC 27001Salesforce Marketing Cloud Account EngagementLinkedInCowboy.

What is Sight's email format?

Minus sign iconPlus sign icon
Sight's email format typically follows the pattern of First@sightdx.com. Find more Sight email formats with LeadIQ.

How much funding has Sight raised to date?

Minus sign iconPlus sign icon
As of October 2025, Sight has raised $99M in funding. The last funding round occurred on Aug 05, 2020 for $71M.

When was Sight founded?

Minus sign iconPlus sign icon
Sight was founded in 2011.
Sight

Sight

Biotechnology ResearchIsrael51-200 Employees

By analyzing exclusive proprietary multidimensional live-single-cell functional imaging data, digitally generated from millions of live immune cells with our de-risked core technology platform, we discover, develop and deploy multi-function, explainable, and biologically backed imaging-based digital signatures. With unprecedented clinical accuracy, we are pioneering a new generation of immune signatures, to predict, detect, guide therapies, and profile the immune system state across health and disease, aiming to solve the greatest immune-related clinical challenges, one immune signature at a time.

Section iconCompany Overview

Headquarters
23 Menahem Begin street, Tel Aviv, Israel 6618356, IL
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
INAQ-WT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconFunding & Financials

  • $99M

    Sight has raised a total of $99M of funding over 2 rounds. Their latest funding round was raised on Aug 05, 2020 in the amount of $71Mas a Series D.

  • $1M$10M

    Sight's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $99M

    Sight has raised a total of $99M of funding over 2 rounds. Their latest funding round was raised on Aug 05, 2020 in the amount of $71Mas a Series D.

  • $1M$10M

    Sight's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.